Continuing Medical Education (CME) Information
CME Accreditation Statement: This activity ("APC 2013 Annual Meeting") is being planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Society for Clinical Pathology (ASCP) and the Association of Pathology Chairs (APC). ASCP is accredited by the ACCME to provide continuing medical education for physicians.
The ASCP designates this "live" educational activity ("APC 2013 Annual Meeting") for a maximum of 25 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Receiving CME Credit for this meeting is a two part process: 1) payment of the application fee; and 2) submission of a meeting evaluation. A CME certificate will not be issued unless both parts are completed. If you are unsure if you submitted both the payment and the evaluation, please contact the APC Office at 301-634-7408. To receive credit, CME application fees and meeting evaluations are due by September 15, 2013.
Disclosure of Financial Relationships and Resolution of Conflicts of Interest: In order to ensure balance, independence, objectivity and scientific rigor in all its educational activities, and in accordance with ACCME Standards, the ASCP requires all individuals in a position to influence and/or control the content of ASCP CME activities to disclose to the ASCP and subsequently to learners whether they do or do not have any relevant financial relationships with proprietary entities producing health care goods or services that are discussed in CME activities. Faculty are asked to use generic names in any discussion of therapeutic options, to base patient care recommendations on scientific evidence, and to base information regarding commercial products/services on scientific methods generally accepted by the medical community. All ASCP CME activities are evaluated by participants for the presence of any commercial bias and this input is used for subsequent CME planning decisions. The primary purpose of this activity is educational and the comments, opinions and/or recommendations expressed by the faculty or authors are their own and not those of ASCP or APC.
None of the planning committee members for this educational activity disclosed a relevant financial relationship. Presenters that indicate relevant financial relationships will be reviewed and conflicts of interest resolved. The following presenters have indicated relationships that have been reviewed and commercial conflicts of interest resolved. In all cases, it was determined that the financial relationship did not relate to the educational assignment or that the commercial entity does not produce, market, re-sell or distribute health care goods or services consumed by, or used on patients. If a presenter is not listed, then he/she had no commercial interest to disclose.
Invited Speaker Disclosures:
J. Charles Jennette, MD, University of North Carolina at Chapel Hill School of Medicine
Commercial Interest: Genentech Role: Consultant/Speaker Compensation: Consulting Fees
Commercial Interest: GlaxoSmithKline Role: Consultant Compensation: Consulting Fees
Commercial Interest: Amicus Therapeutics Role: Consultant Compensation: Consulting Fees
Michael Prystowsky, MD, PhD, Albert Einstein College of Medicine of Yeshiva University
Commercial Interest: G2 Intelligence Role: Speaker Compensation: Honorarium
Thomas Wheeler, MD, Baylor College of Medicine
Commercial Interest: DigiPath Role: Advisory Board Compensation: Stock Options
Questions? email@example.com or 301-634-7880